Lotan Y - Search Results

1

A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Up Staging.

de Jong JJ, Liu Y, Boorjian SA, Bivalacqua TJ, Porten SP, Wheeler T, Davicioni E, Svatek RS, Boormans JL, Black PC, Lotan Y, Gibb EA. de Jong JJ, et al. Among authors: lotan y. J Urol. 2020 Aug;204(2):239-246. doi: 10.1097/JU.0000000000000798. Epub 2020 Feb 14. J Urol. 2020. PMID: 32074006

2

Differential expression of nuclear retinoid receptors in normal and malignant prostates.

Lotan Y, Xu XC, Shalev M, Lotan R, Williams R, Wheeler TM, Thompson TC, Kadmon D. Lotan Y, et al. Among authors: lotan r. J Clin Oncol. 2000 Jan;18(1):116-21. doi: 10.1200/JCO.2000.18.1.116. J Clin Oncol. 2000. PMID: 10623701 Clinical Trial.

3

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.

Lotan Y, Roehrborn CG. Lotan Y, et al. J Urol. 2002 Jan;167(1):75-9. J Urol. 2002. PMID: 11743279

4

Transvaginal laparoscopic nephrectomy: development and feasibility in the porcine model.

Gettman MT, Lotan Y, Napper CA, Cadeddu JA. Gettman MT, et al. Among authors: lotan y. Urology. 2002 Mar;59(3):446-50. doi: 10.1016/s0090-4295(01)01568-0. Urology. 2002. PMID: 11880100

5

Management of ureteral calculi: a cost comparison and decision making analysis.

Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Lotan Y, et al. J Urol. 2002 Apr;167(4):1621-9. J Urol. 2002. PMID: 11912376 Review.

6

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

Lotan Y, Roehrborn CG. Lotan Y, et al. Urology. 2003 Jan;61(1):109-18; discussion 118. doi: 10.1016/s0090-4295(02)02136-2. Urology. 2003. PMID: 12559279 Review.

7

Histopathology of surgically managed renal tumors: analysis of a contemporary series.

Duchene DA, Lotan Y, Cadeddu JA, Sagalowsky AI, Koeneman KS. Duchene DA, et al. Among authors: lotan y. Urology. 2003 Nov;62(5):827-30. doi: 10.1016/s0090-4295(03)00658-7. Urology. 2003. PMID: 14624902 Review.

8

The effects of radio frequency ablation on renal function and blood pressure.

Johnson DB, Taylor GD, Lotan Y, Sagalowsky AI, Koenemann KS, Cadeddu JA. Johnson DB, et al. Among authors: lotan y. J Urol. 2003 Dec;170(6 Pt 1):2234-6. doi: 10.1097/01.ju.0000096265.22657.e8. J Urol. 2003. PMID: 14634386

9

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

10

Cost-effectiveness of medical management strategies for nephrolithiasis.

Lotan Y, Cadeddu JA, Roerhborn CG, Pak CY, Pearle MS. Lotan Y, et al. J Urol. 2004 Dec;172(6 Pt 1):2275-81. doi: 10.1097/01.ju.0000141498.11720.20. J Urol. 2004. PMID: 15538248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters